HAIC Versus Systemic Chemotherapy for Unresectable ICC
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion
chemotherapy (HAIC) of irinotecan, oxaliplatin, 5-fluorouracil and leucovorin compared
systemic chemotherapy of gemcitabine and oxaliplatin in patients with unresectable
intrahepatic cholangiocarcinoma.